ConductScience.org, home

Paper3494555

Cloned human cytotoxic T lymphocytes develop anomalous killer cell function.

Burns GF and 2 others. Clin Exp Immunol, 1986. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Cloned human cytotoxic T lymphocytes develop anomalous killer cell function. Papers, record 3494555. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3494555

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cloned human cytotoxic T lymphocytes develop anomalous killer cell function.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burns GFG F
2Triglia TT
3Werkmeister JAJ A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
T-Lymphocytes, CytotoxicMajor topic
Antigens
B-Lymphocytes
Binding, Competitive
Cell Transformation, Viral
Clone Cells
Cytotoxicity, Immunologic
Humans
Interleukin-2
Melanoma, Experimental

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16194213Blockade of NK cell lysis is a property of monoclonal antibodies that bind to distinct regions of T-200.J Immunol1983https://conductscience.org/library/papers/6194213PubMed
26192076Lymphokine-driven "differentiation" of cytotoxic T-cell clones into cells with NK-like specificity: correlations with display of membrane macromolecules.Immunol Rev1983https://conductscience.org/library/papers/6192076PubMed
36197466Loss of specificity in cytolytic T lymphocyte clones obtained by limit dilution culture of Ly-2+ T cells.J Immunol1984https://conductscience.org/library/papers/6197466PubMed
46608725Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6608725PubMed
56204000A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells.J Exp Med1984https://conductscience.org/library/papers/6204000PubMed
66205072Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.J Immunol1984https://conductscience.org/library/papers/6205072PubMed
76236274Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.J Exp Med1984https://conductscience.org/library/papers/6236274PubMed
86679886
Clonal expansion of human B73.1-positive natural killer cells or large granular lymphocytes exerting strong antibody-dependent and -independent cytotoxicity and occasionally lectin-dependent cytotoxicity.
Nat Immun Cell Growth Regul1983https://conductscience.org/library/papers/6679886PubMed
92580933TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors.J Exp Med1985https://conductscience.org/library/papers/2580933PubMed
103158401
In vitro generation of human activated lymphocyte killer cells. II. N-acetyl-D-galactosamine inhibits a distinct subpopulation of human activated lymphocyte killer cells generated in mixed lymphocyte culture.
Cell Immunol1985https://conductscience.org/library/papers/3158401PubMed
113889158The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.J Immunol1985https://conductscience.org/library/papers/3889158PubMed
123873498Identification of a structure on human melanoma cells recognized by CTL exhibiting anomalous killer cell function.J Immunol1985https://conductscience.org/library/papers/3873498PubMed
132412835
Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor.
Eur J Immunol1985https://conductscience.org/library/papers/2412835PubMed
143903508Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.N Engl J Med1985https://conductscience.org/library/papers/3903508PubMed
156803172A differentiation factor required for the expression of cytotoxic T-cell function.Nature1982https://conductscience.org/library/papers/6803172PubMed
166978927Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.J Exp Med1982https://conductscience.org/library/papers/6978927PubMed
176980937Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen.J Immunol1982https://conductscience.org/library/papers/6980937PubMed
186600253Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.J Immunol1983https://conductscience.org/library/papers/6600253PubMed
196220056Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.J Immunol1983https://conductscience.org/library/papers/6220056PubMed
206300247In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.J Immunol1983https://conductscience.org/library/papers/6300247PubMed

See all 22 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn Papers
2451830Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2451830

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ITGAL3683PubTator's text mininghttps://conductscience.org/library/genes/3683

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3494555

GET https://conductscience.org/api/papers/v1/3494555/references?page=2